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Gerald SMA Kerner1*, Alexander Fischer2, Michel JB Koole3, Jan Pruim3,4 and Harry JM Groen1Abstract
Background: Deformable image registration allows volume of interest (VOI)- and voxel-based analysis of longitudinal
changes in fluorodeoxyglucose (FDG) tumor uptake in patients with non-small cell lung cancer (NSCLC). This
study evaluates the performance of the elastix toolbox deformable image registration algorithm for VOI and
voxel-wise assessment of longitudinal variations in FDG tumor uptake in NSCLC patients.
Methods: Evaluation of the elastix toolbox was performed using 18F-FDG PET/CT at baseline and after 2 cycles of
therapy (follow-up) data in advanced NSCLC patients. The elastix toolbox, an integrated part of the IMALYTICS
workstation, was used to apply a CT-based non-linear image registration of follow-up PET/CT data using the baseline
PET/CT data as reference. Lesion statistics were compared to assess the impact on therapy response assessment. Next,
CT-based deformable image registration was performed anew on the deformed follow-up PET/CT data using the
original follow-up PET/CT data as reference, yielding a realigned follow-up PET dataset. Performance was evaluated by
determining the correlation coefficient between original and realigned follow-up PET datasets. The intra- and
extra-thoracic tumors were automatically delineated on the original PET using a 41% of maximum standardized
uptake value (SUVmax) adaptive threshold. Equivalence between reference and realigned images was tested
(determining 95% range of the difference) and estimating the percentage of voxel values that fell within that range.
Results: Thirty-nine patients with 191 tumor lesions were included. In 37/39 and 12/39 patients, respectively, thoracic
and non-thoracic lesions were evaluable for response assessment. Using the EORTC/SUVmax-based criteria, 5/37 patients
had a discordant response of thoracic, and 2/12 a discordant response of non-thoracic lesions between the reference
and the realigned image. FDG uptake values of corresponding tumor voxels in the original and realigned reference PET
correlated well (R2=0.98). Using equivalence testing, 94% of all the voxel values fell within the 95% range of the
difference between original and realigned reference PET.
Conclusions: The elastix toolbox impacts lesion statistics and therefore therapy response assessment in a
clinically significant way. The elastix toolbox is therefore not applicable in its current form and/or standard
settings for PET response evaluation. Further optimization and validation of this technique is necessary prior to
clinical implementation.
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Tumor response during or after treatment is an import-
ant surrogate marker for survival in oncological patients.
Most commonly, tumor response is measured with CT
using predefined anatomical criteria such as the Re-
sponse Evaluation Criteria in Solid Tumors (RECIST)
criteria or volumetric criteria [1]. In the past years,
metabolic response assessment with 18 F-FDG PET has
gained importance for patients treated with chemother-
apy. Especially for patients who are treated with tyrosine
kinase inhibitors, metabolic lesion changes as measured
with PET have been proven to precede lesion size alter-
ations measurable with CT [2-4]. In order to standardize
metabolic response assessment with 18 F-FDG PET, the
European Organization for Research and Treatment of
Cancer (EORTC) recommendations and more recently
the PERCIST criteria were drafted as guidance for clin-
ical practice [5,6].
Traditionally, 18 F-FDG lesion uptake is quantified by
the maximum and/or mean standardized uptake value
(SUV) of tumor lesions. Although these measures (spe-
cifically maximum standardized uptake value (SUVmax))
have a prognostic value in a variety of cancers, including
non-small cell lung cancer (NSCLC) [7-10], flaws in
SUV quantification can be introduced by a variety of
factors including the type of equipment used, differences
in PET acquisition protocols, reconstruction parameters,
analysis procedures, and image statistics. Moreover, tex-
tural changes in tumor heterogeneity better reflect
tumor response and survival than SUV quantification
alone [11].
Consequently, research efforts have attempted to im-
prove the predictive nature of PET by taking into ac-
count all voxel values and using voxel-wise approaches
for image analysis. For other imaging modalities, such as
MR imaging, a so-called voxel-by-voxel analysis is well
established. It has been proven to be a viable technique
for measuring therapy response in breast cancer [12],
while for high-grade glioma, it was predictive for the
overall survival rate [13]. Voxel-based analysis has also
been applied to response assessment with PET images in
head and neck cancer patients and was shown to be a
useful tool [14].
Deformable image registration may help to improve
tumor response assessment. The elastix toolbox is a
modular computer program for intensity-based medical
image registration. The elastix toolbox [15] has been
validated for thoracic deformable CT to CT image regis-
tration demonstrating a good overall performance com-
pared to other available algorithms [16]. Theoretically,
this algorithm can also be applied to the PET/CT data-
sets using the corresponding sequentially acquired low-
dose CT data. Because of the public domain nature of
the program, the modular adaptability, and the previousgood performance, the toolbox has been integrated with
the propagated align algorithm to perform PET/CT to
PET/CT deformable image registration. To the best of
our knowledge, the performance of the elastix toolbox
on the alignment of solid lung tumors or the impact on
intratumoral distribution of 18 F-FDG uptake has not
been assessed so far. The aim of this study is to evaluate
the applicability of the elastix deformable registration for
a volume of interest (VOI)-based evaluation of lesion
statistics.
Methods
Baseline VOIs and transformed and interpolated follow-
up data and a voxel-by-voxel longitudinal mapping of 18
F-FDG uptake in a clinical setting of patients with
advanced NSCLC were used. For this evaluation, the dif-
ferent steps necessary to perform PET/CT to PET/CT
alignment with the elastix toolbox were integrated in the
IMALYTICS Research Workstation to make the CT-
based deformable registration functionality for thoracic
and extra-thoracic lesions available to clinical end users
and researchers.
Patients and tumor lesions
Patients with advanced (stages III and IV) NSCLC were
studied. All underwent serial 18 F-FDG PET/CT prior to
and after 6 weeks of chemotherapy as part of routine
clinical care. No consent was necessary from the Medical
Ethics Committee because of the retrospective nature of
this study, under the Dutch Medical Research involving
Human Subjects Act.
18 F-FDG PET/CT
18 F-FDG PET/CT scanning was performed on a Siemens
Biograph mCT 64 slice PET/CT scanner (Siemens
Healthcare, Erlangen, Germany). Blood glucose levels
were consistently checked and recorded. All values were
below 11 mmol/L. A weight-dependent 18 F-FDG dose
(3 MBq/kg bodyweight) was administered to the patients
intravenously, and 60 min post-injection PET/CT scan
was acquired from the mid-thigh to the brain [17]. Prior
to PET imaging, a low-dose CT scan was acquired cra-
niocaudally during shallow breathing. Effective tube
current was 24 mAs, tube voltage of 100 kV and care
dose switched on. Slice thickness was 2 mm, and pitch
1.5 with a gantry rotation time of 0.5 s.
PET imaging was performed with a scan time per bed
position dependent on patient weight. Scan time per bed
position was 1 min for a patient weighing less than
60 kg, 2 min for a patient weighing between 60 and
90 kg, and 3 min for a patient weighing above 90 kg
[17]. PET data were corrected for attenuation using the
low-dose CT data while a delayed coincidence window
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ter correction was applied.
PET data were reconstructed using a transaxial image
matrix of 256 × 256 and an ordered subset expectation
maximization (OSEM) algorithm taking advantage of
time of flight information and modeling the system re-
sponse. This scheme used 3 iterations each consisting of
21 subsets. The reconstructed volumetric voxel size was
3.2 × 3.2 × 2.0 mm (20.8 mm3). A Gaussian filter with 8-
mm full width half maximum (FWHM) was used to
smooth the reconstructed data, such that recovery coef-
ficients were in line with EANM guidelines [18].
Per patient multiple metabolically active tumor lesions
were delineated on the reference and the baseline scan
using the 41% adaptive thresholding technique [19]. VOI
lesions were classified as both thoracic with presumed
movement errors and extra-thoracic localization with
minimal movement errors. Lesions were defined as thor-
acic if they were within the lung, mediastinum, and in or
against the interior side of the thoracic wall. The largest
thoracic lesion was defined as the primary tumor.
CT-based response assessment
Contrast-enhanced CT of the thorax was performed on
the Biograph mCT in the same session. Scanning was
performed craniocaudally in 8 s, with breath hold at
inspiration. Effective tube current was 80 mAs with tube
voltage of 120 kV and care dose settings on. Slice thick-
ness was 0.5 mm, and pitch was 1.4 with a gantry rota-
tion time of 0.5 s. Patients were injected with 55 mL of
Iomeron contrast (350 mg/mL) at a speed of 2.5 mL/s,
starting 30 s before the start of the scan. Tumor
response was measured on CT according to RECIST 1.1
criteria [1].
Propagated align algorithm function
The propagated align algorithm, which is part of the PC-
based IMALYTICS Research Workstation (Philips Innova-
tive Technologies GmbH, Aachen, Germany) is based
on the elastix toolbox (version 4.6), a public domain
computer program for intensity-based medical image
registration [15]. The elastix-based propagated align al-
gorithm incorporates a graphical user interface and
provides a cubic B-spline-based non-linear algorithm to
correct for deformations. Rigid and deformable image
registration is performed on the low-dose CT data, and
the resulting transformations are thereafter applied on
the sequentially acquired PET scans.
CT to CT registration errors were previously investi-
gated and known to be small [16,20]. Consequently, they
were not further studied in this paper.
The procedure for the deformable registration of a
target PET/CT dataset to a reference PET/CT dataset
is as follows:1. The rigid transformation for optimal alignment of
the target CT to the reference CT dataset is
determined.
2. Subsequently, the resulting rigid transformation
(translation and rotation) is applied to the target
PET to ensure that the target PET properly aligns to
the reference PET.
3. Next, a non-rigid transformation is performed on
the rigidly aligned CT images as discussed by Klein
et al. [15]. The result is a deformation vector field
(Table 1) based on cubic B-splines mapping the
rigidly transformed target CT onto the reference
CT. For quality assurance, the Jacobian determinant
(Table 1) of the deformation vector field is extracted
as well, since it provides information on the local
deformations (expansion/contraction). No additional
constraints to the deformation field are imposed.
4. The following step is to propagate the deformation
field to the rigidly aligned PET images from step 2.
In this way, target PET images are deformed to
spatially match the reference PET data.
The fusion steps are also detailed in Figure 1. All
transformation calculations used a four-level multi-
resolution approach while mutual information as
image similarity measure, and an adaptive stochastic
gradient descent optimizer [21] was used to maximize
image similarity. The control point spacing of the B-
spline transformation was 16 mm. The maximum
number of iterations was set to 250 (rigid) and 500 (B-
spline). Because of computation time, data were proc-
essed in batch mode using python scripting.
Quality assessment of the image registration was per-
formed systematically by visually comparing each non-
rigidly aligned CT to the reference CT scan.Longitudinal VOI-based and voxel-by-voxel analysis
All previous steps are necessary in order to achieve de-
formable image registration of PET images acquired at
different time points. Next, the deformed or ‘warped’
image registration was evaluated in terms of both lesion
statistics and voxel-by-voxel mapping of tumoral 18 F-
FDG uptake.
First, the lesion statistics were investigated as follows:
the follow-up PET data were transformed and interpolated
to the spatial voxel locations of the baseline PET data.
Tumor delineations of the baseline PET scan were used to
calculate lesion statistics of both baseline and the aligned
follow-up data. These findings were compared with the
lesion statistics determined on the original (non-warped)
follow-up PET data. This was done in order to evaluate
the impact of deformed and interpolated follow-up data
on therapy response assessment.
Figure 1 Fusion steps of the propagated align algorithm. Reg-rigid: rigidly registered image. Reg-elastix: rigid and non-rigidly registered
image. Step 1: rigid CT to CT alignment of target to reference. Step 2: translation of step 1 on target PET. Step 3: CT to rigid aligned CT non-rigid
alignment using elastix toolbox. Step 4: translation of step 3 to PET of step 2. QA: resample of image as quality assurance, so voxel size matches
prior to voxel-by-voxel comparison.
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tumoral 18 F-FDG uptake between different PET time
points, the original follow-up dataset was aligned to the
baseline PET/CT (which was used for the lesion statis-
tics). An elastix deformable image registration was per-
formed again to realign the warped follow-up dataset
back with the original follow-up dataset. The aim is to
assess to which extent the original follow-up tumor uptake
values is preserved by applying image registration using
the elastix toolbox. If there were any large discrepancies (i.
e., <80% alignment using ΔSUV), we further investigated
the reason for this low alignment percentage.
Impact of PET signal to noise ratio (SNR) on the voxel-by-
voxel analysis
Signal to noise measurements were performed by defin-
ing VOIs in healthy pulmonary and hepatic tissue of the
original PET data. A spherical VOI of 5 cm diameter
was placed in the right lobe of the liver, while a 3-cm-
diameter spherical VOI was positioned in healthy lung
tissue.
Statistics
The correlation coefficient between original and rea-
ligned tumor uptake values (SUV) was determined using
Pearson’s R test. The difference between original and
realigned tumor uptake values was calculated both as
the difference in standard uptake values (ΔSUV) and the
difference in percentage of the original SUV (Δ percent-
age). Equivalence between original and realigned follow-
up tumor uptake values was assessed by a Bland-Altmananalysis with the original follow-up tumor data used as
reference method. For the Bland-Altman analysis, ΔSUV
and Δ% SUV corresponding to the 95% limits of agree-
ment was determined taking into account the tumor
voxels of all measurable tumor lesions in all patients.
To assess the influence of spatial discrepancies be-
tween PET and CT data due to respiratory and cardiac
motion, equivalence between original and realigned
tumor uptake values was assessed per patient separately
for thoracic and extra-thoracic lesions. The significance
of the equivalence between thoracic and extra-thoracic
lesions was assessed using a chi-square test.
To assess the effects of SNR, the mean activity of the
lung and liver spherical VOI were divided by the stand-
ard deviation (SD) of the activity. This was performed to
estimate for the signal to noise ratio. Impact of the PET
SNR on the voxel-by-voxel statistical analysis was evalu-
ated by assessing the relationship between PET SNR and
equivalence between original and realigned tumor up-
take values.
All statistical analyses were performed using SPSS
version 20.0 (International Business Machines Corp,
Armonk, NY, USA). Nominal P values less than 0.05
were considered significant.
Results
A total of 39 patients were evaluated. There were 37
patients with stage IV disease and 2 with stage III. Me-
dian age was 59 (21 to 79) years, and male/female ratio
was 14/25. Body weight changed less than 1 kg during
the study.
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For each of the 39 patients, a median (range) number of
3 (1 to 20) VOIs were delineated on the original baseline
fluorodeoxyglucose (FDG) PET scan with per tumor
VOI localization. The range of the volume of the pri-
mary tumor was 2.4 to 556.8 mL (median 25.5 mL), and
for the metastasis, it was 1.2 to 390 mL (median
7.8 mL). For the 39 patients, a total of 191 different tu-
mors (primaries and metastases) consisting of 295,219
tumor voxels (6,141 mL) were considered.Equivalence of the original and realigned baseline tumor
uptake values
On visual assessment, all target CT aligned properly to the
respective reference CT. There was a good relationship
between the voxel values of the original and elastix ad-
justed images (Pearson correlation test; R2 0.98; P < 0.01).Equivalence testing using ΔSUV
The SD of the ΔSUV between reference and target im-
ages was 0.74. With the range of the 95% limits of agree-
ment defined as between −1.46 and 1.46 ΔSUV, a total
of 94% of all voxels was accurately aligned within the
range, or in other words, 6% of the voxels mismatched
(Figure 2). Using ΔSUV, 34 patients had a thoracic align-
ment (i.e., the voxel percentage with an alignment within
the 95% estimated range) of above 80%. Five patients
had an alignment less than 80% (Table 1; see below).
The extra-thoracic locations aligned above 90% of the
voxels in all patients implicating that movement control
was adequate (Table 1).Figure 2 Equivalence plot between reference and realigned images of 3A typical example of a patient is shown in Figure 3, with
the reference, target and target minus reference image.
Further study of the 5 patients with a voxel alignment
<80% revealed that the reason for misalignment in gen-
eral was due to CT- to PET-specific-related inaccuracies.
In some patients, these inaccuracies were specific to
therapy as it involved tumor necrosis (Figure 4). The
other reason for an inaccuracy was the subsequent pres-
ence or absence of collapsed lung tissue after therapy
(Additional file 1: Table S1).
Equivalence testing using Δ percentage
The SD of the Δ percentage between reference and tar-
get images was 13%. With the range of the 95% limits of
agreement defined as between −25 and 25 Δ percentage,
a total of 93% of voxels aligned within this range, which
means that 7% of the voxels mismatched using this
method. The alignment percentage per patient using
ΔSUV and Δ percentage is detailed in Table 2.
There was no relation between the alignment percent-
age and tumor response (Figure 5), signal to noise ratio
of either the liver or normal parts of the lung, or with
the distribution of the original SUV.
Assessment of effects on SUVmax
It was not possible to perform simultaneous measurement
of the SUVmax in two patients. One (nr. 23) had only a
solitary extra-thoracic metastasis. The other patient (nr.
32) had at baseline no measurable thoracic lesions; how-
ever, there was a significant amount of measurable lesions
after 6 weeks of therapy. The median difference of SUVmax
of the primary tumor between the elastix adjusted to9 patients. 94% of the voxels are within the 95% range of the difference.
Table 1 Alignment percentage per patient between elastix and baseline image of intra- and extra-thoracic measurable lesions
Pts Thoracic Extra-thoracic
Age Sex RECIST N % ΔSUV %Δ perc. N % ΔSUV %Δ perc.
1. 60 F PR 2 92 67 -
2. 44 F PD 1 92 99 -
3. 55 F SD 3 96 90 -
4. 79 F PR 2 99 94 -
5. 70 F PR 1 100 87 -
6. 21 F PR 3 97 95 3 100 100
7. 65 M SD 5 57* 90 4 90 97
8. 57 F PR 7 86 81 -
9. 62 F PR 1 97 91 1 100 85
10. 48 F SD 1 92 37 -
11. 65 M PD 3 87 87 13 96 98
12. 49 F SD 3 100 97 2 100 96
13. 43 M SD 1 100 100 5 99 99
14. 65 F PR 2 78* 76 -
15. 51 F SD 6 98 94 -
16. 52 M SD 6 100 97 -
17. 72 F SD 1 95 94 -
18. 56 F PD 3 73* 93 1 93 93
19. 71 M PR 1 88 79 -
20. 55 F PR 1 78* 84 -
21. 40 F PR 2 100 89 6 99 94
22. 62 F SD 2 100 95 2 100 100
23. 62 F SD 0 ** 1 100 100
24. 56 F SD 2 100 99 -
25. 75 M PR 3 100 86 -
26. 47 F PR 1 100 92 -
27. 54 M PR 9 91 84 9 100 97
28. 65 M SD 3 96 97 -
29. 59 F SD 5 94 97 -
30. 72 M SD 1 89 94 -
31. 63 M PR 8 96 68 -












Table 1 Alignment percentage per patient between elastix and baseline image of intra- and extra-thoracic measurable lesions (Continued)
33. 36 F PR 1 99 87 -
34. 64 F PD 6 100 100 4 100 100
35. 40 F PD 4 90 80 6 99 78
36. 40 M SD 2 96 90 5 100 96
37. 61 M PR 1 100 88 1 100 96
38 68 M PR 1 51* 57 -
39. 26 F CR 3 91 75 1 99 91
Total 14 M/25 F 115 76
Median 59 96 90 100 96
N, number of measurable lesions per patient; % ΔSUV, percentage of the voxels that fall within the 95% limits of agreement of −1.46 to 1.46 ΔSUV; % Δ% perc., percentage of the voxels that fall within the 95% limits
of agreement of −25 to 25 Δ percentage; CR, complete response; PR, partial response; SD: stabile disease; PD, progressive disease; −, no extra-thoracic lesions present. *Misalignment caused by adjacent normal tissue.












Figure 3 Original (A), elastix adjusted (B), and subtraction(C) maximum intensity projection of patient 6. These images show the typical
results before and after alignment as well as the difference between these two images.
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to 6.8 SUV), while for extra-thoracic lesions it was −0.6
SUV (−4.3 to 3.1 SUV). When measured using the EORTC
criteria, concerning the primary tumor, 5/37 patients had a
discordant response, whereas in the extra-thoracic lesions,
2/12 patients had a discordant response (Table 2).
Discussion
In this study, we investigated whether a non-linear re-
alignment of PET images using the elastix toolbox can.Figure 4 Example image of patient 7: baseline (A), reference (B), elas
and active tumor tissue between the two scans (and no visible decrease in an
within the 95% limits of agreement of −1.46 to 1.46 ΔSUV. However, on crudebe used for therapy assessment on patients with NSCLC.
This allows the reuse of baseline lesion delineations for
the quantification of tracer uptake in tumor lesions at
follow-up. Also, it may facilitate therapy response assess-
ment using EORTC or PERCIST criteria. Furthermore,
this approach may allow an automated volumetric voxel-
by-voxel analysis as it delivers more information on
tumor changes. Changes in the distribution of voxels
under the influence of treatment in terms of percentage vi-
able voxels (i.e., percentage above or below a predetermined;
tix adjusted (C) and subtraction (D). Because of a mix of non-active
atomic tumor size with stable disease), only 57% of the voxels aligned
visual assessment, the images look very similar.
Table 2 SUVmax of thoracic and non-thoracic lesions and the difference between original and elastix adjusted image
Pts Thoracic Extra-thoracic
RECIST Original Elastix Difference Original Elastix Difference
1. PR 5.5 6.5 1.0
2. PD 18.2 18.2 0.0
3. SD 6.9 7.3 0.4
4. PR 6.4 7.1 0.7
5. PR 3.8 4.0 0.2
6. PR 11.2 10.8 −0.4 4.6 3.1 −1.4
7. SD 25.5 30.8 5.3
8. PR 10.7 10.7 0
9. PR 5.9 6.5 0.6 4.2 4.5 0.3
10. SD 4.1 3.6 −0.5
11. PD 13.6 9.8 −3.8 14.5 10.2 −4.3
12. SD 7.2 6.8 −0.4 6.5 3.1 −3.4
13. SD 1.8 1.7 −0.1 12.3 11.4 −0.9
14. PR 10.8 12.3 1.5
15. SD 7.7 6.6 −1.1
16. SD 7.0 6.4 −0.6
17. SD 10.1 9.3 −0.8
18. PD 24.2 31.0 6.8
19. PR 6.3 4.5 −1.8
20. PR 12.0 12.0 0
21. PR 4.7 6.3 1.6 7.0 9.1 2.1
22. SD 6.8 6.8 0.0 3.4 2.3 −1.2
23. SD * 5.6 4.7 −0.9
24. SD 7.2 7.0 −0.3
25. PR 3.9 4.2 0.3
26. PR 3.0 2.9 0.1
27. PR 6.5 8.2 1.7 2.9 6.1 3.1
28. SD 14.1 9.0 −5.2
29. SD 18.8 18.3 −0.5
30. SD 14.8 15.4 0.7
31. PR 5.9 6.5 0.6
32. PD * 9.8 11.4 1.7
33. PR 5.0 4.8 −0.2
34. PD 11.4 11.7 0.3 7.4 7.6 0.2
35. PD 6.3 5.3 −1.0 2.6 2.3 −0.3
36. SD 6.3 4.1 −2.2
37. PR 4.1 4.2 0.1
38 PR 13.2 13.3 0.1
39. CR 4.0 5.1 1.1
*No thoracic lesion measurable, RECIST 1.1 response assessment. CR, complete response; PR, partial response; SD, stabile disease; PD, progressive disease.
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Figure 5 Relation between thoracic imaging alignment and
tumor response according to RECIST criteria per patient. RECIST
tumor response was not related to the thoracic alignment percentage.
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better indicator of efficacy and consequently have prognos-
tic value. In order to make this method feasible, a reliable
alignment technique for PET scans is paramount. We used
the elastix toolbox which had shown good performance in
different CT-based thoracic alignment studies [22,23].
Anatomical information such as lung boundaries and major
lung fissures and correspondence to annotated landmark
pairs were used, and the results showed a good perform-
ance. The toolbox makes use of a cubic B-spline non-linear
algorithm which shows good mass preservation between
inspiration and expiration CT scans [24]. Our study not
only used the CT-based alignment of the elastix toolbox
but also projected this alignment on the corresponding 18
F-FDG PET images, and the performance was assessed
using both lesion statistics and voxel-by-voxel analysis.
Our results show that the method has significant im-
pact on lesion statistics. This impact, with differences
between −5 and 7 ΔSUV in thoracic lesions, is clinically
relevant. First of all, such large spread of 12 SUV affects
the interpretation of the results in a clinically significant
way. Secondly, we observed changes in the response as-
sessment in 5 out of 37 (14%) patients using the 1999
EORTC response proposal. The elastix toolbox settings
were optimized for CT-CT registration where the align-
ment of anatomical structures in the lungs was theprimary target. For longitudinal PET quantification,
other settings might be more appropriate. On the other
hand, the approach for volumetric tumor analysis used
by van Velden et al. where instead of interpolating
follow-up data to match baseline voxel locations, the
baseline VOIs are projected onto the follow-up data,
may be considered more appropriate for longitudinal
tracer quantification [25]. The reason that it might be
more appropriate is that this approach does not allow a
voxel-by-voxel analysis but allows a more accurate quan-
tification of global tumor characteristics such as
SUVmax.
The second goal of using deformable image registra-
tion and realigning follow-up with baseline data was to
be able to measure more accurately intratumoral hetero-
geneity (textural analysis) and response to treatment in a
more detailed manner. This is important, as initially
measured high intratumoral heterogeneity on 18 F-FDG
PET is related both to poor prognosis and to resistance
to treatment [26]. We demonstrate that the original
intratumoral tracer distribution indeed can be preserved
by using a forward and backward deformable image
registration. This means that the registration process is
nearly invertible and information about intratumoral
tracer distribution is preserved to a great extent during
the registration.
The propagated align algorithm itself is a shell that
makes the multiple steps necessary for performing de-
formable image registration using the elastix toolbox
more user friendly. It provides an automated method to
perform not just the multiple steps per patient but also
the multiple patients per instance. It can also be adapted
to other deformable image registration methods.
Methodological shortcomings
There are some factors that negatively influence the ap-
plication of this technique.
First, in 5 patients, there was a voxel misalignment in
the thorax, which was caused by the presence of medias-
tinal tissue directly adjacent to the tumor tissue. We
need to consider that the first step of the alignment
method is based on anatomical CT changes and that on
CT, hardly no difference can be made between the col-
lapsed lung, tumor necrosis, or mediastinal tissue,
whereas PET can do so. Consequently, in these cases,
the method will introduce discrepancies, that will need
further attention.
Second, as was seen with the SUVmax measurement, in
some patients, the SUVmax was different with a wide-
spread on the elastix adjusted image and the original
image. This effect was particularly pronounced in thor-
acic lesions. However, because the voxel-by-voxel
analysis showed that values correspond well after for-
ward and backward transformations, it suggests that the
Kerner et al. EJNMMI Research  (2015) 5:15 Page 11 of 12corresponding transformation is practically invertible.
This is a concern that needs further optimization of the
algorithm and limits the applicability of the algorithm in
its current stage. This problem could be exacerbated due
to the use of 3D instead of 4D PET. A previous study
showed significant differences in textural features be-
tween static 3D and respiratory-gated 4D PET/CT [27].
The same study showed higher uptake and less blurring
in the 4D PET images compared to the corresponding
3D PET images [27].
Third, we were not able to further compare the tex-
tural features between the images. Textural features can
predict disease recurrence and survival, sometimes more
powerfully than the current global measurements used
in clinical practice [11,26]. This should be the subject of
future studies.
Conclusions
Comparative imaging analyses with an automated voxel-
by-voxel technique are a promising tool for tumor evalu-
ation in patients with advanced NSCLC. However, the
elastix toolbox impacts lesion statistics and therefore
therapy response assessment in a clinically significant
way. Consequently, the elastix toolbox is not applicable
in its current form and/or standard settings for response
evaluation. It remains to be determined to which extent
the intratumoral uptake distribution is preserved when
this type of deformable image registration is applied.
Further optimization and validation is necessary due to
the inaccuracies observed in this study. The propagated
align algorithm provides the shell for performing
deformable image registration, in this case, using the elas-
tix toolbox. The propagated align algorithm itself could be
adapted for performing deformable image registration
using other techniques.
Additional files
Additional file 1: Table S1. Reason for less than 80% alignment using
ΔSUV.
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